Koninklijke Philips NV (XAMS:PHIA)
€ 24.81 -0.06 (-0.24%) Market Cap: 23.12 Bil Enterprise Value: 29.57 Bil PE Ratio: 0 PB Ratio: 1.95 GF Score: 70/100

Koninklijke Philips NV Provides Update on Philips Respironics' PE-PUR Sound Abatement Foam Test and Research Program Call Transcript

Jun 28, 2022 / 07:00AM GMT
Release Date Price: €18.94 (-1.85%)
FranÃ;ois Adrianus van Houten
Koninklijke Philips N.V. - Chairman of the Board of Management & CEO

§ -

Today, we are providing an update on the extensive test and research program launched in June 2021, for the Respironics field safety notice for specific CPAP, BiPAP and mechanical ventilator devices. I've asked Roy Jakobs to join me here and provide some important context on the repair and replacement program, which we also refer to as the remediation program.

Roy is a member of our Executive Committee, and he leads the Philips Connected Care businesses that include Philips Respironics. Roy oversees the remediation program and other aspects of the field action. Let me emphasize just how important patient safety and quality are to Philips.

Improving the health and well-being of people is at the heart of our company purpose. We pride ourselves on the fact that people all over the world use our products, services and solutions to live healthier lives and to care for patients. I know how important these sleep apnea devices are to patients and how they improve their lives.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot